MARY WALKER: Open Payments
NPI 1881281350 · BEL AIR, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$148 in 6 payments from 5 companies in 2025. Trend: 2023 $305 · 2024 $494 · 2025 $148
Food & beverage: $148
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $52 |
| Sumitomo Pharma America, Inc. | 1 | $28 |
| Organon LLC | 1 | $27 |
| Supernus Pharmaceuticals, Inc. | 1 | $22 |
| Soleno Therapeutics, Inc. | 1 | $20 |
Products named: Veozah, GEMTESA, NEXPLANON, Qelbree, VYKAT XR.
Industry payments across MD — which companies pay providers there.
